The reticulocyte-mediated release of iron and bicarbonate from transferrin: effect of metabolic inhibitors.
D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology*; D001151:Arsenic / Q000494:pharmacology; D001386:Azides / Q000494:pharmacology; D001639:Bicarbonates / Q000378:metabolism*; D001665:Binding Sites; D002250:Carbon Radioisotopes; D003035:Cobalt / Q000494:pharmacology; D003486:Cyanides / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D004140:Dinitrophenols / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology; D005459:Fluorides / Q000494:pharmacology; D006418:Heme / Q000494:pharmacology; D007461:Iodoacetates / Q000494:pharmacology; D007501:Iron / Q000378:metabolism*; D007504:Iron Radioisotopes; D007538:Isoniazid / Q000494:pharmacology; D009840:Oligomycins / Q000494:pharmacology; D011485:Protein Binding; D012156:Reticulocytes / Q000187:drug effects / Q000378:metabolism*; D012402:Rotenone / Q000494:pharmacology; D013997:Time Factors; D014168:Transferrin / Q000378:metabolism*
D000963:Antimetabolites; D001386:Azides; D001639:Bicarbonates; D002250:Carbon Radioisotopes; D003486:Cyanides; D004140:Dinitrophenols; D007461:Iodoacetates; D007504:Iron Radioisotopes; D009840:Oligomycins; D014168:Transferrin; D012402:Rotenone; D003035:Cobalt; D006418:Heme; D003513:Cycloheximide; D007501:Iron; D001151:Arsenic; D005033:Ethylmaleimide; D005459:Fluorides; D007538:Isoniazid